Clinical Trial

Parent Study Name: Pulmonary Rehabilitation to Reduce Post-Tuberculosis Morbidity (TB Pure)

Study acronym: TB Pure
Recruiting
View on ClinicalTrials.gov →
Summary
Individual-level, unblinded randomized controlled trial of an 8-week (short arm) or 24-week (extended arm) pulmonary rehabilitation program, relative to standard of care, to prevent post-tuberculosis respiratory morbidity. Randomization will occur in a 1:1:1 ratio at the initiation of treatment.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2025-09-02; most recent amendment 2026-03-25.
Status change: Not Yet Recruiting → Recruiting 2026-03-25
Trial Details
NCT Number NCT07164742
Lead Sponsor Johns Hopkins University
Collaborators: National Institute of Allergy and Infectious Diseases (NIAID)
Conditions TB - Tuberculosis, TB, TB Infection
Enrollment 690 participants
Start Date 2026-03-18
Primary Completion 2028-09-15 (estimated)
Study Completion 2028-09-15 (estimated)
Updated on ClinicalTrials.gov 2026-03-27